Black Rock Inc. Akero Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,586,637 shares of AKRO stock, worth $158 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,586,637
Previous 4,892,616
14.19%
Holding current value
$158 Million
Previous $124 Million
6.05%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AKRO
# of Institutions
190Shares Held
73.8MCall Options Held
241KPut Options Held
647K-
Wellington Management Group LLP Boston, MA7.9MShares$224 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X07.08MShares$201 Million0.11% of portfolio
-
Rtw Investments, LP New York, NY5.92MShares$168 Million2.71% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$148 Million4.29% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.81MShares$108 Million0.01% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.32B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...